Listening to MS: AI-assisted speech analysis for diagnosis and fatigue prediction (COMMITMENT) - Scorecard - MDSpire

Listening to MS: AI-assisted speech analysis for diagnosis and fatigue prediction (COMMITMENT)

  • By

  • Helly Hammer

  • Monica Gonzalez-Machorro

  • Pascal Hecker

  • Uwe Reichel

  • Alisha Zmutt

  • Lisa Pedrotti

  • Andrew Chan

  • Florian Eyben

  • Hesam Sagha

  • Matthias Kahlau

  • Bert Arnrich

  • Björn W. Schuller

  • Robert Hoepner

  • May 29, 2026

  • 0 min

Share

Clinical Scorecard: Utilizing AI-Enhanced Speech Analysis for Diagnosing Multiple Sclerosis and Predicting Fatigue Levels

At a Glance

CategoryDetail
Condition
Key MechanismsAI-based speech analysis to identify vocal biomarkers for fatigue, as per study findings.
Target Population
Care Setting

Key Highlights

  • Remove unsupported claims about fatigue prevalence and specificity.

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider AI-assisted speech analysis as a complementary tool for fatigue assessment, as suggested by the study.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Revise to reflect findings without unsupported conclusions.

        Clinical Best Practices

        • Incorporate objective measures alongside subjective assessments for fatigue in pwMS, as per study findings.

        Related Resources & Content

        Original Source(s)

        Listening to MS: AI-assisted speech analysis for diagnosis and fatigue prediction (COMMITMENT)

        • by Helly Hammer, Monica Gonzalez-Machorro, Pascal Hecker, Uwe Reichel, Alisha Zmutt, Lisa Pedrotti, Andrew Chan, Florian Eyben, Hesam Sagha, Matthias Kahlau, Bert Arnrich, Björn W. Schuller, Robert Hoepner

        • May 29, 2026

        Related Content

        Clinical implications of natalizumab Fab-arm exchange in patients with multiple sclerosis

        Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis Activity

        Physical disability, cognition, and depression as determinants of quality of life in multiple sclerosis: a cross-sectional study